Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 26 peer-reviewed journal articles Updated
Neurology

Daily Management of Movement, Speech, and Feeding

At a Glance

Daily care for NEDAMSS is individualized around comfort, safety, and participation. A coordinated team can manage movement problems, check whether food or liquid is entering the lungs without warning, support nutrition, recognize pain, and introduce communication tools as speech changes.

Managing the daily impact of NEDAMSS requires a shift toward “symptomatic management”—focusing on comfort, safety, and maintaining the best possible quality of life [1]. Because NEDAMSS is ultra-rare, there is no single “standard protocol.” Instead, care is individualized by a multidisciplinary team, including neurologists, physical therapists (PT), occupational therapists (OT), and speech-language pathologists (SLP) [2][3].

Addressing Movement and Muscle Tone

Children with NEDAMSS often experience a mix of spasticity (velocity-dependent stiffness), dystonia (twisting/posturing), and ataxia (unsteadiness) [4].

  • Medications: While evidence for specific drugs in NEDAMSS is individualized, doctors may trial oral medications such as baclofen (for spasticity) or trihexyphenidyl (for dystonia) [5][6]. If movement issues are localized to specific limbs, botulinum toxin (Botox) injections may be used to temporarily relax those muscles [6]. It is important to know that these interventions can cause side effects such as sedation, weakness, dry mouth, constipation, or worsened swallowing, and dosing requires specialist supervision.
  • Physical and Occupational Therapy: These therapies focus on “functional goals”—like helping your child sit comfortably, move safely, or play [7].
    • Contracture Prevention: Regular, individualized stretching and proper positioning by your PT/OT can help prevent contractures, where muscles and tendons become permanently shortened and painful [8][9].
    • Adaptive Equipment: Your team may recommend specialized seating, standing frames, or orthoses (braces) to support your child’s body and allow them to participate in daily activities [10][11].
  • Pain Management: Pain is common but often “silent” in children with severe motor disabilities. Daily acts like dressing, transfers, or physical therapy can be painful [12][13]. Using a validated tool like the revised FLACC scale (r-FLACC) can help you and your doctors identify and treat pain before it worsens muscle stiffness [12]. Caregiver-specific pain behaviors may need to be added to this scale.

Managing Swallowing and Nutrition

Because NEDAMSS affects the muscles used for eating, dysphagia (difficulty swallowing) is a significant concern. The goal is to prevent aspiration, which is when food or liquid “goes down the wrong pipe” into the lungs [14].

  • Silent Aspiration: Some children with NEDAMSS can “silently” aspirate, meaning they breathe food or liquid into their lungs without coughing or choking [15][16].
  • Specialized Testing: If clinical assessment indicates a risk (like wet-sounding breathing, frequent coughing, or slow weight gain), your doctor may order a VFSS (an X-ray of the swallow) or a FEES (using a small camera) to check for safety rather than ordering them at a universal interval [17][18].
  • Feeding Strategies: Your team may recommend thickening liquids, changing the flow rate of bottles, or adjusting your child’s head position during meals [19][20]. These changes should be made only after assessment and instruction by a qualified feeding team, as the wrong texture or position can sometimes worsen aspiration or hydration.
  • Enteral Nutrition: If oral feeding becomes too risky or if your child cannot take in enough calories, a G-tube (gastrostomy tube) may be recommended to ensure they remain hydrated and well-nourished [21][22]. This should be a shared decision; note that a G-tube does not eliminate the aspiration of saliva or severe reflux.

Bridging the Gap in Communication

The loss of spoken language (regression) is one of the most challenging aspects of NEDAMSS. However, the loss of speech does not mean your child has lost the desire to communicate.

  • AAC (Augmentative and Alternative Communication): Moving early to AAC tools can help bridge the gap, and the system should be reassessed as motor abilities change. This might include:
    • Low-tech: Picture boards, sign language, or specific gestures [23][24].
    • High-tech: Speech-generating devices or eye-tracking technology [23].
  • Individualized Therapy: Speech-language pathologists work to find the system that best matches your child’s current motor abilities, often using gestures or individualized training to encourage communication and reduce frustration [25][26].

By focusing on these daily management strategies, the goal is to maximize your child’s comfort and their ability to engage with the world around them.

Common questions in this guide

What treatments can help my child’s stiffness and abnormal movements in NEDAMSS?
Care is individualized to your child’s movement pattern and goals. A clinician may trial baclofen for stiffness, trihexyphenidyl for dystonia, or botulinum toxin for selected muscles. Physical and occupational therapy, stretching, positioning, seating, and braces can support comfort and function, but medicines and injections require specialist monitoring for sleepiness, weakness, dry mouth, constipation, or swallowing changes.
How can I tell whether my child is having swallowing problems or aspiration?
Aspiration means food or liquid enters the lungs, and it can happen without coughing or choking. Wet-sounding breathing, frequent coughing, or slow weight gain can prompt a clinical assessment, followed when needed by a video X-ray swallow study called VFSS or a camera-based exam called FEES.
What feeding changes are safe for a child with NEDAMSS?
A feeding team may recommend thickened liquids, a different bottle flow, or a change in head position after assessing your child’s swallowing. Do not make these changes without professional instruction, because the wrong texture or position can worsen aspiration or reduce hydration.
How can my child communicate after losing spoken words?
Augmentative and alternative communication, or AAC, can include picture boards, signs, gestures, speech-generating devices, or eye-tracking technology. A speech-language pathologist can match the system to your child’s motor abilities and reassess it as those abilities change.
How can caregivers recognize pain when a child cannot describe it?
Pain may show up as changes in movement, facial expression, behavior, or increased stiffness during dressing, transfers, or therapy. The revised FLACC scale can help caregivers and clinicians track pain, but it should be adapted to the child’s individual pain behaviors.
When might a G-tube be considered for a child with NEDAMSS?
A G-tube may be considered when eating by mouth is unsafe or does not provide enough calories or fluids. It can support nutrition and hydration but does not prevent saliva from entering the lungs or eliminate severe reflux, so the decision should be shared with the care team.

Get notified when new evidence is published on IRF2BPL-related regressive neurodevelopmental disorder-dystonia-seizures syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (26)
  1. 1

    Novel human neurodevelopmental and neurodegenerative disease associated with IRF2BPL gene variants-mechanisms and therapeutic avenues.

    Bauersachs D, Bomholtz L, Del Rey Mateos S, et al.

    Frontiers in neuroscience 2024; (18()):1426177 doi:10.3389/fnins.2024.1426177.

    PMID: 38903604
  2. 2

    IRF2BPL-Related Disorder, Causing Neurodevelopmental Disorder with Regression, Abnormal Movements, Loss of Speech and Seizures (NEDAMSS) Is Characterized by Pathology Consistent with DRPLA.

    Venkateswaran S, Michaud J, Ito Y, et al.

    Movement disorders : official journal of the Movement Disorder Society 2024; (39(11)):2102-2109 doi:10.1002/mds.29938.

    PMID: 39224955
  3. 3

    Clinical characterization of IRF2BPL mutation: Case series and review of the literature.

    Lou X, Li W, Pang M, et al.

    Medicine 2025; (104(1)):e41078 doi:10.1097/MD.0000000000041078.

    PMID: 40184118
  4. 4

    Genetic analysis of IRF2BPL in a Taiwanese dystonia cohort: The genotype and phenotype correlation.

    Chen PS, Chen YF, Chiu JY, et al.

    Annals of clinical and translational neurology 2024; (11(6)):1557-1566 doi:10.1002/acn3.52072.

    PMID: 38650104
  5. 5

    Fifteen-minute consultation: Approach to investigation and management of childhood dystonia.

    Forman EB, King MD, Gorman KM

    Archives of disease in childhood. Education and practice edition 2021; (106(2)):71-77 doi:10.1136/archdischild-2019-318131.

    PMID: 32928841
  6. 6

    Pharmacological management of abnormal tone and movement in cerebral palsy.

    Lumsden DE, Crowe B, Basu A, et al.

    Archives of disease in childhood 2019; (104(8)):775-780 doi:10.1136/archdischild-2018-316309.

    PMID: 30948360
  7. 7

    Integrating the ICF and the F-Words Framework to Support Family-Centered Pediatric Care for Children with Neurodevelopmental Disorders: A Narrative Review.

    Gogola A, Gnat R, Skworc A, et al.

    Children (Basel, Switzerland) 2026; (13(3)) doi:10.3390/children13030354.

    PMID: 41897067
  8. 8

    Neurophysiological and Neuroanatomical Background of Spasticity: Surgical Implication for Dorsal Rhizotomy in Cerebral Palsy.

    Sindou M, Joud A, Georgoulis G

    Advances and technical standards in neurosurgery 2025; (51()):15-39 doi:10.1007/978-3-031-86441-4_3.

    PMID: 40445338
  9. 9

    Dutch rehabilitation physicians' perspectives on contracture management in children with spinal muscular atrophy: challenges in a changing landscape.

    Oude Lansink ILB, Beelen A, Kruitwagen-van Reenen E, et al.

    Frontiers in neurology 2025; (16()):1670391 doi:10.3389/fneur.2025.1670391.

    PMID: 41451418
  10. 10

    Sensor-based outcomes to monitor everyday life motor activities of children and adolescents with neuromotor impairments: A survey with health professionals.

    Rast FM, Labruyère R

    Frontiers in rehabilitation sciences 2022; (3()):865701 doi:10.3389/fresc.2022.865701.

    PMID: 36311205
  11. 11

    Pediatric Rehabilitation Medicine Physicians: Your Essential Medical Home Neighbors for Children with Disabilities.

    Bosques G, Houtrow AJ, Holman LK

    Pediatric clinics of North America 2023; (70(3)):371-384 doi:10.1016/j.pcl.2023.01.001.

    PMID: 37121631
  12. 12

    Incidence and risk factors for care-related pain in children with physical disabilities.

    Dubois A, Hall C, Courtois-Communier E, et al.

    European journal of physical and rehabilitation medicine 2023; (59(3)):414-424 doi:10.23736/S1973-9087.23.07726-2.

    PMID: 37184414
  13. 13

    Care-related pain and discomfort in children with motor disabilities in rehabilitation centres.

    Bourseul JS, Brochard S, Houx L, et al.

    Annals of physical and rehabilitation medicine 2016; (59(5-6)):314-319 doi:10.1016/j.rehab.2016.04.009.

    PMID: 27315695
  14. 14

    IRF2BPL as a novel causative gene for progressive myoclonus epilepsy.

    Gardella E, Michelucci R, Christensen HM, et al.

    Epilepsia 2023; (64(8)):e170-e176 doi:10.1111/epi.17634.

    PMID: 37114479
  15. 15

    Clinical identification of feeding and swallowing disorders in 0-6 month old infants with Down syndrome.

    Stanley MA, Shepherd N, Duvall N, et al.

    American journal of medical genetics. Part A 2019; (179(2)):177-182 doi:10.1002/ajmg.a.11.

    PMID: 30588741
  16. 16

    Presenting Signs and Symptoms do not Predict Aspiration Risk in Children.

    Duncan DR, Mitchell PD, Larson K, Rosen RL

    The Journal of pediatrics 2018; (201()):141-146 doi:10.1016/j.jpeds.2018.05.030.

    PMID: 29960768
  17. 17

    Dysphagia Management in Children: Implementation and Perspectives of Flexible Endoscopic Evaluation of Swallowing (FEES).

    Printza A, Sdravou K, Triaridis S

    Children (Basel, Switzerland) 2022; (9(12)) doi:10.3390/children9121857.

    PMID: 36553301
  18. 18

    Fiberoptic Endoscopic Evaluation of Swallowing in Infants and Children: Protocol, Safety, and Clinical Efficacy: 25 Years of Experience.

    Miller CK, Willging JP

    The Annals of otology, rhinology, and laryngology 2020; (129(5)):469-481 doi:10.1177/0003489419893720.

    PMID: 31845586
  19. 19

    Thickened Liquids Improve Infant Swallow Function as Measured by Penetration-Aspiration Scale Score on Videofluoroscopic Swallow Study.

    Golden C, Kim M, Larson K, Duncan DR

    Pediatric pulmonology 2025; (60(11)):e71363 doi:10.1002/ppul.71363.

    PMID: 41217422
  20. 20

    Feeding Interventions Are Associated With Improved Outcomes in Children With Laryngeal Penetration.

    Duncan DR, Larson K, Davidson K, et al.

    Journal of pediatric gastroenterology and nutrition 2019; (68(2)):218-224 doi:10.1097/MPG.0000000000002167.

    PMID: 30320668
  21. 21

    European Society for Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for the Evaluation and Treatment of Gastrointestinal and Nutritional Complications in Children With Neurological Impairment.

    Romano C, van Wynckel M, Hulst J, et al.

    Journal of pediatric gastroenterology and nutrition 2017; (65(2)):242-264 doi:10.1097/MPG.0000000000001646.

    PMID: 28737572
  22. 22

    The Management of Swallowing Disorders in Children With Spinal Muscular Atrophy Type 1: A Scoping Review.

    Rocca S, Pizzi L, Pizzorni N, et al.

    American journal of speech-language pathology 2026; 1-22 doi:10.1044/2026_AJSLP-25-00460.

    PMID: 42776174
  23. 23

    Digital technology interventions for communication skills in persons with neurodevelopmental disorders: a scoping review.

    Zorzi S, Lubkina V, Jēkabsone I, Berteotti L

    Research in developmental disabilities 2025; (164()):105080 doi:10.1016/j.ridd.2025.105080.

    PMID: 40737720
  24. 24

    Speech and language in DDX3X-neurodevelopmental disorder: A call for early augmentative and alternative communication intervention.

    Forbes EJ, Morison LD, Lelik F, et al.

    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2024; (195(6)):e32971 doi:10.1002/ajmg.b.32971.

    PMID: 38421120
  25. 25

    Tact Training with Augmentative Gestural Support for Language Disorder and Challenging Behaviors: A Case Study in an Italian Community-Based Setting.

    Turriziani L, Vartellini R, Barcello MG, et al.

    Journal of clinical medicine 2024; (13(22)) doi:10.3390/jcm13226790.

    PMID: 39597934
  26. 26

    Perceived quality and needs in speech-language therapy for Spanish children with Rett and Angelman Syndromes.

    Cañamero LM, García-Blanco A, Udeanu A

    Journal of communication disorders 2026; (122()):106658 doi:10.1016/j.jcomdis.2026.106658.

    PMID: 42134237

This page explains daily management strategies for children with NEDAMSS for informational purposes only and does not constitute medical advice. Your child’s neurology, rehabilitation, feeding, and communication teams should tailor medicines, equipment, nutrition plans, and therapies to their needs.

Guide contents IRF2BPL-related regressive neurodevelopmental disorder-dystonia-seizures syndrome
Research & Literature
04 Managing Seizures and Neurological Emergencies 06 Building Your Care Team and Future Research